SORL1 mutations in early- and late-onset Alzheimer disease

Michael Cuccaro, Regina M. Carney, Yalun Zhang, Christopher Bohm, Brian W. Kunkle, Badri N. Vardarajan, Patrice L. Whitehead, Holly N Cukier, Richard Mayeux, Peter St George-Hyslop, Margaret A Pericak-Vance

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: To characterize the clinical and molecular effect of mutations in the sortilin-related receptor (SORL1) gene. Methods: We performed whole-exome sequencing in early-onset Alzheimer disease (EOAD) and late-onset Alzheimer disease (LOAD) families followed by functional studies of select variants. The phenotypic consequences associated with SORL1 mutations were characterized based on clinical reviews of medical records. Functional studies were completed to evaluate b-amyloid (Ab) production and amyloid precursor protein (APP) trafficking associated with SORL1 mutations. Results: SORL1 alterations were present in 2 EOAD families. In one, a SORL1 T588I change was identified in 4 individuals with AD, 2 of whom had parkinsonian features. In the second, an SORL1 T2134 alteration was found in 3 of 4 AD cases, one of whom had postmortem Lewy bodies. Among LOAD cases, 4 individuals with either SORL1 A528T or T947M alterations had parkinsonian features. Functionally, the variants weaken the interaction of the SORL1 protein with full-length APP, altering levels of Ab and interfering with APP trafficking. Conclusions: The findings from this study support an important role for SORL1 mutations in AD pathogenesis by way of altering Ab levels and interfering with APP trafficking. In addition, the presence of parkinsonian features among select individuals with AD and SORL1 mutations merits further investigation.

Original languageEnglish (US)
Article numbere116
JournalNeurology: Genetics
Volume2
Issue number6
DOIs
StatePublished - Jan 1 2016

Fingerprint

Alzheimer Disease
Amyloid
Protein Transport
Mutation
Exome
Lewy Bodies
Amyloid beta-Protein Precursor
Medical Records
Genes
Proteins

ASJC Scopus subject areas

  • Clinical Neurology
  • Genetics(clinical)

Cite this

SORL1 mutations in early- and late-onset Alzheimer disease. / Cuccaro, Michael; Carney, Regina M.; Zhang, Yalun; Bohm, Christopher; Kunkle, Brian W.; Vardarajan, Badri N.; Whitehead, Patrice L.; Cukier, Holly N; Mayeux, Richard; George-Hyslop, Peter St; Pericak-Vance, Margaret A.

In: Neurology: Genetics, Vol. 2, No. 6, e116, 01.01.2016.

Research output: Contribution to journalArticle

Cuccaro, M, Carney, RM, Zhang, Y, Bohm, C, Kunkle, BW, Vardarajan, BN, Whitehead, PL, Cukier, HN, Mayeux, R, George-Hyslop, PS & Pericak-Vance, MA 2016, 'SORL1 mutations in early- and late-onset Alzheimer disease', Neurology: Genetics, vol. 2, no. 6, e116. https://doi.org/10.1212/NXG.0000000000000116
Cuccaro M, Carney RM, Zhang Y, Bohm C, Kunkle BW, Vardarajan BN et al. SORL1 mutations in early- and late-onset Alzheimer disease. Neurology: Genetics. 2016 Jan 1;2(6). e116. https://doi.org/10.1212/NXG.0000000000000116
Cuccaro, Michael ; Carney, Regina M. ; Zhang, Yalun ; Bohm, Christopher ; Kunkle, Brian W. ; Vardarajan, Badri N. ; Whitehead, Patrice L. ; Cukier, Holly N ; Mayeux, Richard ; George-Hyslop, Peter St ; Pericak-Vance, Margaret A. / SORL1 mutations in early- and late-onset Alzheimer disease. In: Neurology: Genetics. 2016 ; Vol. 2, No. 6.
@article{145d129d42d944c0943fd34915f39518,
title = "SORL1 mutations in early- and late-onset Alzheimer disease",
abstract = "Objective: To characterize the clinical and molecular effect of mutations in the sortilin-related receptor (SORL1) gene. Methods: We performed whole-exome sequencing in early-onset Alzheimer disease (EOAD) and late-onset Alzheimer disease (LOAD) families followed by functional studies of select variants. The phenotypic consequences associated with SORL1 mutations were characterized based on clinical reviews of medical records. Functional studies were completed to evaluate b-amyloid (Ab) production and amyloid precursor protein (APP) trafficking associated with SORL1 mutations. Results: SORL1 alterations were present in 2 EOAD families. In one, a SORL1 T588I change was identified in 4 individuals with AD, 2 of whom had parkinsonian features. In the second, an SORL1 T2134 alteration was found in 3 of 4 AD cases, one of whom had postmortem Lewy bodies. Among LOAD cases, 4 individuals with either SORL1 A528T or T947M alterations had parkinsonian features. Functionally, the variants weaken the interaction of the SORL1 protein with full-length APP, altering levels of Ab and interfering with APP trafficking. Conclusions: The findings from this study support an important role for SORL1 mutations in AD pathogenesis by way of altering Ab levels and interfering with APP trafficking. In addition, the presence of parkinsonian features among select individuals with AD and SORL1 mutations merits further investigation.",
author = "Michael Cuccaro and Carney, {Regina M.} and Yalun Zhang and Christopher Bohm and Kunkle, {Brian W.} and Vardarajan, {Badri N.} and Whitehead, {Patrice L.} and Cukier, {Holly N} and Richard Mayeux and George-Hyslop, {Peter St} and Pericak-Vance, {Margaret A}",
year = "2016",
month = "1",
day = "1",
doi = "10.1212/NXG.0000000000000116",
language = "English (US)",
volume = "2",
journal = "Neurology: Genetics",
issn = "2376-7839",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - SORL1 mutations in early- and late-onset Alzheimer disease

AU - Cuccaro, Michael

AU - Carney, Regina M.

AU - Zhang, Yalun

AU - Bohm, Christopher

AU - Kunkle, Brian W.

AU - Vardarajan, Badri N.

AU - Whitehead, Patrice L.

AU - Cukier, Holly N

AU - Mayeux, Richard

AU - George-Hyslop, Peter St

AU - Pericak-Vance, Margaret A

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Objective: To characterize the clinical and molecular effect of mutations in the sortilin-related receptor (SORL1) gene. Methods: We performed whole-exome sequencing in early-onset Alzheimer disease (EOAD) and late-onset Alzheimer disease (LOAD) families followed by functional studies of select variants. The phenotypic consequences associated with SORL1 mutations were characterized based on clinical reviews of medical records. Functional studies were completed to evaluate b-amyloid (Ab) production and amyloid precursor protein (APP) trafficking associated with SORL1 mutations. Results: SORL1 alterations were present in 2 EOAD families. In one, a SORL1 T588I change was identified in 4 individuals with AD, 2 of whom had parkinsonian features. In the second, an SORL1 T2134 alteration was found in 3 of 4 AD cases, one of whom had postmortem Lewy bodies. Among LOAD cases, 4 individuals with either SORL1 A528T or T947M alterations had parkinsonian features. Functionally, the variants weaken the interaction of the SORL1 protein with full-length APP, altering levels of Ab and interfering with APP trafficking. Conclusions: The findings from this study support an important role for SORL1 mutations in AD pathogenesis by way of altering Ab levels and interfering with APP trafficking. In addition, the presence of parkinsonian features among select individuals with AD and SORL1 mutations merits further investigation.

AB - Objective: To characterize the clinical and molecular effect of mutations in the sortilin-related receptor (SORL1) gene. Methods: We performed whole-exome sequencing in early-onset Alzheimer disease (EOAD) and late-onset Alzheimer disease (LOAD) families followed by functional studies of select variants. The phenotypic consequences associated with SORL1 mutations were characterized based on clinical reviews of medical records. Functional studies were completed to evaluate b-amyloid (Ab) production and amyloid precursor protein (APP) trafficking associated with SORL1 mutations. Results: SORL1 alterations were present in 2 EOAD families. In one, a SORL1 T588I change was identified in 4 individuals with AD, 2 of whom had parkinsonian features. In the second, an SORL1 T2134 alteration was found in 3 of 4 AD cases, one of whom had postmortem Lewy bodies. Among LOAD cases, 4 individuals with either SORL1 A528T or T947M alterations had parkinsonian features. Functionally, the variants weaken the interaction of the SORL1 protein with full-length APP, altering levels of Ab and interfering with APP trafficking. Conclusions: The findings from this study support an important role for SORL1 mutations in AD pathogenesis by way of altering Ab levels and interfering with APP trafficking. In addition, the presence of parkinsonian features among select individuals with AD and SORL1 mutations merits further investigation.

UR - http://www.scopus.com/inward/record.url?scp=85026528738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026528738&partnerID=8YFLogxK

U2 - 10.1212/NXG.0000000000000116

DO - 10.1212/NXG.0000000000000116

M3 - Article

AN - SCOPUS:85026528738

VL - 2

JO - Neurology: Genetics

JF - Neurology: Genetics

SN - 2376-7839

IS - 6

M1 - e116

ER -